The persistent threat of parasitic disease remains one of the most significant hurdles in modern livestock and poultry management, often leading to reduced growth rates, impaired immunity, and substantial economic losses. For veterinary professionals and farm managers, the challenge lies not just in treatment, but in sourcing pharmaceutical-grade solutions that guarantee consistent bioavailability.
Since 2008, Shijiazhuang Huajun Animal Pharmaceutical Co., Ltd. (ZTHJ Pharma) has addressed these challenges by integrating advanced R&D with high-tech production. Operating from a 21,000 square meter state-of-the-art facility in Xinle City, we provide specialized Ivermectin/Albendazole formulations that meet the rigorous 2022 GMP standards of the Ministry of Agriculture. Our commitment to excellence ensures that every batch serves as a definitive solution to complex infestation cycles, protecting your animal assets with precision-engineered medicine.
Technical superiority in antiparasitic pharmacology is defined by molecular stability and delivery efficiency. Our production lines for powder, premix, and oral solutions are designed to optimize the synergistic effects of Ivermectin/Albendazole, ensuring broad-spectrum efficacy against both internal and external parasites.
| Performance Metric | Industry Significance | Our Engineering Standard | Advantage |
|---|---|---|---|
| Manufacturing Compliance | Ensures safety and legal adherence | New Veterinary Drug GMP (2022) | Guaranteed global export quality and safety. |
| Formulation Diversity | Targeted delivery for different species | Powder, Premix, and Liquid Mixed Additives | Flexible administration across poultry, pets, and livestock. |
| R&D Foundation | Product innovation and potency | Integration of Specific Antigens & Peptides | Enhanced therapeutic index compared to generic alternatives. |
| Scalability | Supply chain reliability | 100+ Product Varieties in a 21,000m² Hub | Consistent supply for large-scale international operations. |
Investing in high-tier veterinary medicine is a strategic financial decision. By utilizing our Ivermectin/Albendazole solutions, producers can significantly lower the "Total Cost of Health" by reducing the frequency of re-treatment and improving Feed Conversion Ratios (FCR). Our international presence—spanning markets from Arabic-speaking regions to Europe—reflects the global trust in our ability to deliver long-term value through pharmaceutical innovation.
The following data highlights the comparative efficacy of our standardized antiparasitic protocols in stabilizing herd health compared to traditional methods.
As a global leader in animal health, Shijiazhuang Huajun continues to pioneer pharmaceutical guides for Ivermectin/Albendazole, ensuring that our partners achieve the highest possible return on their livestock investments through science-backed parasitic control.
Related products
Top Selling Products
